Advertisement Epistem contract research division IHC laboratories wins GCLP status - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Epistem contract research division IHC laboratories wins GCLP status

Epistem's contract research division has received good clinical laboratory practice (GCLP) accreditation status for its histology and immunohistochemistry (IHC) laboratories.

GCLP status indicates that the operation standards of the contract research division are compliant with the British Association of Research Quality Assurance standards.

Epistem contract research division co-founder and managing director Catherine Booth said, "Accreditation strengthens our clinical biomarker capabilities enabling us to support regulatory submissions from partners who use our technology and expertise globally."

The contract research division offers solutions supporting preclinical testing and clinical drug development programs within pharmaceutical and biotechnology organizations

A specialized histology and IHC service in UK Human Tissue Authority accredited laboratories is offered.

Antibody novel labeling protocols and quality controlled data sets and publication quality images are also offered by the company.